MicroPort Endovascular MedTech (Shanghai) Co., Ltd. (688016)
Overview
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft system; Cratos and Castor, a branched aortic stent graft system; Talos, a thoracic stent graft system; and
Employees822
Market Cap$12.2B
Revenue$1.4B
Listed OnShanghai Stock Exchange
Ticker688016
CEOMr. Qing Zhu Ph.D.
HeadquartersShanghai